ScienceDex / Researcher record
Charles Stewart Kamen
- University of Rochester · Internal Medicine (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #2,624
- Program Leader
- R01 Holder
- Early Career
- Diverse Portfolio
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $3,277,619 | 3 | #2,247 |
| 2025 | $3,463,961 | 3 | #2,650 |
| 2026 | $5,227,676 | 3 | #2,624 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20243 records
- FY20253 records
- FY2026 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10552100Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-4219-4320Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Internal Medicine
FY2026 award records by amount
NIH award records listing Charles Stewart Kamen as a PI. Multi-PI records show the full award amount for context.
- 5UH3CA260602-06UH3Co-investigatorDisparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting$2.4Maward amount
- 5P30CA272302-02P30Contact PIUniversity of Rochester Wilmot Cancer Institute Support GrantUniversity of Rochester · Internal Medicine (NIH department code)$2.1Maward amount
- 5R01CA281862-04R01Co-investigatorA Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors$755.8Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Charles Stewart Kamen as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardRoswell Park Comprehensive Cancer Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2247
- 2024Entered Top 25% NationallyRanked #2247
- 2025$5M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$10M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Charles Stewart Kamen.
Lori Sakoda
Roswell Park Comprehensive Cancer Center
3
shared awards
Christine B. Ambrosone
Roswell Park Comprehensive Cancer Center
2
shared awards
Song Yao
Roswell Park Comprehensive Cancer Center
2
shared awards
Theresa Ann Hastert
University of Rochester
2
shared awards
Theresa E Hahn
Roswell Park Comprehensive Cancer Center
2
shared awards
Bradley N. Mills
University of Rochester
1
shared award
Brian Jay Martin
University of Rochester
1
shared award
Brian Marples
University of Rochester
1
shared award
Darren Richard Carpizo
University of Rochester
1
shared award
Derick R Peterson
University of Rochester
1
shared award